114 related articles for article (PubMed ID: 1761269)
1. [Psychobiology of compulsive disease].
Lesch KP
Fortschr Neurol Psychiatr; 1991 Oct; 59(10):404-12. PubMed ID: 1761269
[TBL] [Abstract][Full Text] [Related]
2. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
[TBL] [Abstract][Full Text] [Related]
3. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
Korff S; Harvey BH
Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
[TBL] [Abstract][Full Text] [Related]
4. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
Winslow JT; Insel TR
J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
[TBL] [Abstract][Full Text] [Related]
5. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
McDougle CJ; Goodman WK; Leckman JF; Price LH
Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
[TBL] [Abstract][Full Text] [Related]
6. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
Murphy DL; Pato MT; Pigott TA
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):91S-100S. PubMed ID: 1973944
[TBL] [Abstract][Full Text] [Related]
7. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
Murphy DL; Pigott TA
J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.
Zohar J; Kennedy JL; Hollander E; Koran LM
J Clin Psychiatry; 2004; 65 Suppl 14():18-21. PubMed ID: 15554784
[TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive disorder.
George MS
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
[TBL] [Abstract][Full Text] [Related]
10. Hallucinogens, serotonin and obsessive-compulsive disorder.
Delgado PL; Moreno FA
J Psychoactive Drugs; 1998; 30(4):359-66. PubMed ID: 9924841
[TBL] [Abstract][Full Text] [Related]
11. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
Steeves TD; Fox SH
Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
[TBL] [Abstract][Full Text] [Related]
12. [Psychosurgical treatment of malignant OCD: three case-reports].
Polosan M; Millet B; Bougerol T; Olié JP; Devaux B
Encephale; 2003; 29(6):545-52. PubMed ID: 15029089
[TBL] [Abstract][Full Text] [Related]
13. [Validity of the neuroethological model of obsessive-compulsive disorder].
Wurthmann C; Bondick I
Fortschr Neurol Psychiatr; 1995 Mar; 63(3):121-5. PubMed ID: 7759048
[TBL] [Abstract][Full Text] [Related]
14. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
Zak JP; Miller JA; Sheehan DV; Fanous BS
J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.
Saxena S; Brody AL; Schwartz JM; Baxter LR
Br J Psychiatry Suppl; 1998; (35):26-37. PubMed ID: 9829024
[TBL] [Abstract][Full Text] [Related]
16. [Obsessive-compulsive disorder and the basal ganglia].
Miguel Filho EC
Arq Neuropsiquiatr; 1995 Dec; 53(4):858-9. PubMed ID: 8729788
[TBL] [Abstract][Full Text] [Related]
17. Altered corticostriatal functional connectivity in obsessive-compulsive disorder.
Harrison BJ; Soriano-Mas C; Pujol J; Ortiz H; López-Solà M; Hernández-Ribas R; Deus J; Alonso P; Yücel M; Pantelis C; Menchon JM; Cardoner N
Arch Gen Psychiatry; 2009 Nov; 66(11):1189-200. PubMed ID: 19884607
[TBL] [Abstract][Full Text] [Related]
18. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers.
Chamberlain SR; Blackwell AD; Fineberg NA; Robbins TW; Sahakian BJ
Neurosci Biobehav Rev; 2005 May; 29(3):399-419. PubMed ID: 15820546
[TBL] [Abstract][Full Text] [Related]
19. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
Barr LC; Goodman WK; Price LH; McDougle CJ; Charney DS
J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
[TBL] [Abstract][Full Text] [Related]
20. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder.
van den Heuvel OA; Veltman DJ; Groenewegen HJ; Cath DC; van Balkom AJ; van Hartskamp J; Barkhof F; van Dyck R
Arch Gen Psychiatry; 2005 Mar; 62(3):301-9. PubMed ID: 15753243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
